KANUMA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug KANUMA contains one active pharmaceutical ingredient (API):

1	Sebelipase alfa UNII K4YTU42T8G - SEBELIPASE ALFA
	Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL). Replacement of LAL enzyme activity leads to reductions in liver fat content and transaminases, and enables metabolism of cholesteryl esters and triglycerides in the lysosome, leading to reductions in lowdensity lipoprotein (LDL) cholesterol and non-high-density lipoprotein (HDL) cholesterol, triglycerides, and increases in HDL cholesterol. Improvement in growth occurs as a result of substrate reduction in the intestine.
	Read more about Sebelipase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KANUMA Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB14		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	565518060000101
CA	Health Products and Food Branch	02469596
EE	Ravimiamet	1695225
ES	Centro de información online de medicamentos de la AEMPS	1151033001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	412241
FR	Base de données publique des médicaments	68773758
GB	Medicines & Healthcare Products Regulatory Agency	309327
IL	מִשְׂרַד הַבְּרִיאוּת	8012
IT	Agenzia del Farmaco	044493017
LT	Valstybinė vaistų kontrolės tarnyba	1077965
NL	Z-Index G-Standaard, PRK	137464
PL	Rejestru Produktów Leczniczych	100354137
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69025001
TR	İlaç ve Tıbbi Cihaz Kurumu	8680131470068
US	FDA, National Drug Code	25682-007